Coronary artery brachytherapy.
Coronary artery disease is the leading cause of mortality in the West with over 1.2 million angioplasties performed annually. Despite the introduction of stents, restenosis occurs in 30-40% of vessels, which until recently has only been treated effectively by coronary artery bypass surgery. Coronary artery brachytherapy appears to provide an alternative, less invasive remedy. The mechanisms of restenosis and how these are inhibited by radiation are described here. The practicalities of radiation delivery and the history of the development of intravascular radiation as an effective clinical tool are outlined. Finally, the pitfalls of the current technology and the areas in which future research must be targeted for the field to develop are discussed.
Department of Cardiac, Vascular and Inflammation Research, Bart's and The London, Queen Mary's School of Medicine and Dentistry, UK.
E C
EC
Sims
M T
MT
Rothman
T D
TD
Warner
M E B
ME
Powell
D000800:Angioplasty, Balloon; D001918:Brachytherapy / Q000009:adverse effects / Q000379:methods*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000532:radiotherapy* / Q000628:therapy; D023903:Coronary Restenosis / Q000503:physiopathology / Q000517:prevention & control*; D006801:Humans; D015607:Stents; D013927:Thrombosis / Q000209:etiology